Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Magnetic resonance spectroscopy in focal brain lesions.

Alam MS, Sajjad Z, Hafeez S, Akhter W.

J Pak Med Assoc. 2011 Jun;61(6):540-3.

2.

Magnetic resonance spectroscopy of enhancing cerebral lesions: analysis of 78 histopathology proven cases.

Alam MS, Ahsan H, Sajjad Z, Beg M, Bhatti U, Enam A, Wasay M.

J Pak Med Assoc. 2014 Oct;64(10):1141-5.

3.

Diffusion weighted MR imaging of ring enhancing brain lesions.

Alam MS, Sajjad Z, Azeemuddin M, Khan ZA, Mubarak F, Akhtar W.

J Coll Physicians Surg Pak. 2012 Jul;22(7):428-31. doi: 07.2012/JCPSP.428431.

PMID:
22747861
4.

Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.

Lai PH, Hsu SS, Ding SW, Ko CW, Fu JH, Weng MJ, Yeh LR, Wu MT, Liang HL, Chen CK, Pan HB.

Surg Neurol. 2007;68 Suppl 1:S25-36.

PMID:
17963918
5.

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.

6.

Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model.

Butzen J, Prost R, Chetty V, Donahue K, Neppl R, Bowen W, Li SJ, Haughton V, Mark L, Kim T, Mueller W, Meyer G, Krouwer H, Rand S.

AJNR Am J Neuroradiol. 2000 Aug;21(7):1213-9.

7.

Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.

Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX.

Chin Med J (Engl). 2009 Jan 5;122(1):39-43.

PMID:
19187615
8.

Magnetic Resonance Spectroscopy: Novel Non-invasive Technique for Diagnosing Brain Tumors.

Rehman L, Rehman UL, Azmat SK, Hashim AS.

J Coll Physicians Surg Pak. 2015 Dec;25(12):863-6. doi: 12.2015/JCPSP.863866.

PMID:
26691358
9.

Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.

Stadler KL, Ober CP, Feeney DA, Jessen CR.

Am J Vet Res. 2014 Nov;75(11):982-9. doi: 10.2460/ajvr.75.11.982.

PMID:
25350088
10.

The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.

Floriano VH, Torres US, Spotti AR, Ferraz-Filho JR, Tognola WA.

PLoS One. 2013 Dec 6;8(12):e81509. doi: 10.1371/journal.pone.0081509. eCollection 2013.

11.

Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions.

Rand SD, Prost R, Haughton V, Mark L, Strainer J, Johansen J, Kim TA, Chetty VK, Mueller W, Meyer G, Krouwer H.

AJNR Am J Neuroradiol. 1997 Oct;18(9):1695-704.

12.

Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.

Balos DR, Gavrilović S, Lavrnić S, Vasić B, Macvanski M, Damjanović D, Opinćal TS.

Vojnosanit Pregl. 2013 Jul;70(7):637-44.

PMID:
23984611
13.

Conventional and advanced magnetic resonance imaging in tumefactive demyelination.

Saini J, Chatterjee S, Thomas B, Kesavadas C.

Acta Radiol. 2011 Dec 1;52(10):1159-68. doi: 10.1258/ar.2011.110007. Epub 2011 Oct 24.

PMID:
22025739
14.

Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.

Porto L, Hattingen E, Stuecher A, Herminghaus S, Lanfermann H, Ulrich Pilatus UP.

J Neurol Surg A Cent Eur Neurosurg. 2012 May;73(3):147-52. doi: 10.1055/s-0032-1313723. Epub 2012 May 3.

PMID:
22190143
15.

[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].

Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, Nakao N, Matsumoto T, Arita N.

Nihon Igaku Hoshasen Gakkai Zasshi. 2004 Mar;64(3):121-6. Japanese.

PMID:
15148787
16.

MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.

Elias AE, Carlos RC, Smith EA, Frechtling D, George B, Maly P, Sundgren PC.

Acad Radiol. 2011 Sep;18(9):1101-8. doi: 10.1016/j.acra.2011.05.006.

PMID:
21820634
18.

Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):516-23.

19.

Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.

Vassiou K, Tsougos I, Kousi E, Vlychou M, Athanasiou E, Theodorou K, Arvanitis DL, Fezoulidis IV.

Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.

PMID:
23436823
20.

In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.

Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y.

Clin Radiol. 2011 Oct;66(10):953-60. doi: 10.1016/j.crad.2011.05.001. Epub 2011 Jun 12.

PMID:
21663899

Supplemental Content

Support Center